SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

11276	Companies
250579	Keywords
179215	Articles
136418	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 08/06/2025 at 07:05, 1 year 2 months ago

Sanofi finalise l'acquisition de Vigil Neuroscience

Acquisition Sanofi Neurologie Vigil Neuroscience VG-3927
PRESS RELEASE

published on 08/06/2025 at 07:00, 1 year 2 months ago

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
Sanofi announces completion of Vigil Neuroscience, Inc. acquisition, reinforcing neurology pipeline with VG-3927 for Alzheimer's. Vigil shareholders receive CVR. VGL101 not acquired

Acquisition Sanofi Neurology Alzheimer's Vigil Neuroscience
PRESS RELEASE

published on 08/06/2025 at 07:00, 1 year 2 months ago

Communiqué de presse : Sanofi finalise l’acquisition de Vigil Neuroscience, Inc.
Sanofi finalise l’acquisition de Vigil Neuroscience, Inc. renforçant son pipeline en neurologie avec le VG-3927 pour la maladie d’Alzheimer. Aucun impact sur les prévisions financières 2025

Acquisition Sanofi Neurologie Vigil Neuroscience VG-3927
BRIEF

published on 07/22/2025 at 07:35, 1 year 3 months ago

Sanofi acquiert Vicebio pour booster son portefeuille de vaccins respiratoires

Acquisition Sanofi Vicebio Vaccins Respiratoires Technologie Molecular Clamp Investissement Biotechnologie
BRIEF

published on 07/22/2025 at 07:35, 1 year 3 months ago

Sanofi acquires Vicebio to boost its respiratory vaccine portfolio

Sanofi Acquisition Vicebio Respiratory Vaccines Molecular Clamp Technology Biotechnology Investment
PRESS RELEASE

published on 07/22/2025 at 07:30, 1 year 3 months ago

Communiqué de presse : Sanofi va acquérir Vicebio et enrichir son pipeline de vaccins respiratoires
Sanofi acquiert Vicebio pour enrichir son pipeline de vaccins respiratoires avec la technologie 'Molecular Clamp'. Accord d'1,15 milliards de dollars. Acquisition renforce l'innovation et le développement de vaccins

Acquisition Sanofi Vicebio Vaccins Respiratoires Molecular Clamp
PRESS RELEASE

published on 07/22/2025 at 07:30, 1 year 3 months ago

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
Sanofi acquires Vicebio, enhancing respiratory vaccines pipeline with 'Molecular Clamp' technology and combination vaccine candidates for RSV and hMPV, expanding capabilities in vaccine development

Sanofi Vicebio Respiratory Vaccines Molecular Clamp Technology Combination Vaccines
BRIEF

published on 07/18/2025 at 07:05, 1 year 3 months ago

Sanofi Completes Acquisition of Blueprint Medicines

Acquisition Sanofi Blueprint Medicines Systemic Mastocytosis Ayvakit
BRIEF

published on 07/18/2025 at 07:05, 1 year 3 months ago

Sanofi finalise l'acquisition de Blueprint Medicines

Acquisition Sanofi Médicaments Blueprint Mastocytose Systémique Ayvakit
PRESS RELEASE

published on 07/18/2025 at 07:00, 1 year 3 months ago

Press Release: Sanofi completes acquisition of Blueprint Medicines
Sanofi completes acquisition of Blueprint Medicines, adding rare immunology disease medicines to its portfolio. The acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis (SM) and elenestinib for SM, enhancing Sanofi's immunology pipeline

Acquisition Sanofi Immunology Blueprint Medicines Ayvakit/Ayvakyt

Accesswire

Published on 11/04/2026 at 23:10, 2 hours 25 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 2 hours 35 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 2 hours 35 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 3 hours 20 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 3 hours 30 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 00:02, 1 hour 32 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 5 hours 53 minutes ago

EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 6 hours 9 minutes ago

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 6 hours 51 minutes ago

EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 7 hours 29 minutes ago

Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production

Les Echos

Published on 11/04/2026 at 18:00, 7 hours 34 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 7 hours 34 minutes ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 7 hours 50 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 7 hours 50 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 7 hours 51 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE